Managing GLP-1 Medications for Long-Term Success While GLP-1 receptor agonists represent a significant advancement in weight management and diabetes treatment, their impact on gut health through altered hydration and nutrient status (plus many other factors) requires thoughtful management
Pack gel ice packs in the cooler for embarkation
Clinical trials revealed significant weight loss with liraglutide at doses of up to 3.0 mg per day, with participants losing an average of 46 kg over 20 weeks, outperforming placebo and orlistat (38)
5 This ease of use has fueled expectations of growing market share for oral GLP-1 formulations, with analysts estimating they could generate $22 billion annually by 2030, capturing 24% of the global weight loss market
Serious Complications of Ozempic, Wegovy, Mounjaro and other GLP-1 Medications GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and others, have been linked to serious gastrointestinal illnesses and serious complications which may result in hospitalization or permanent injury
